Beneo says the Standing Committee on Plant, Animals, Food and Feed has agreed with the European Union (EU) Commission to authorize a second 13.5 health claim for the company’s chicory root fibers.
The announcement comes just three months after the company received its first 13.5 health claim for its chicory inulin at the beginning of 2016.
The recent health claim confirms that inulin and oligofructose contribute to a better blood glucose management as they support a lower rise in blood glucose response.
The wording for the claim may read “Consumption of food/drinks containing inulin/oligofructose instead of sugars induces a lower blood glucose rise after their consumption compared to sugar-containing foods/drinks” when Beneo’s chicory root fibers are used.
The EU Commission will now continue with the publication of the health claim in the EU Official Journal which is expected within four to six weeks.
Consequently, the claim will be able to be used in the market soon.
In addition to the authorized 13.5 health claim, general health-related well-being claims under article 10.3 are also possible.
Amongst others, these may include “lower and more balanced blood glucose rise”.
About 30% sugar reduction needs to be obtained by replacement with non-digestible carbohydrates such as Beneo’s inulin and oligofructose according to the conditions of use.
The authorization is based on several scientific studies all of which confirm that oligofructose and inulin have a significant part to play in the area of glycemic control.
